About Tethis
Tethis is a Technology company based in Milan (Italy) founded in 2004. Automated solutions for liquid biopsy processing are provided. It operates on a HealthTech model in Technology and Healthcare sectors. Tethis has raised $15.33 million across 5 funding rounds from investors including European Union, ENEA Tech e Biomedical and sanpaolope.com. Tethis offers products and services including Liquid Biopsy Solution. Its focus areas include Medical Devices and Diagnostic Equipment. Its legal entity is Tethis S.p.A.
Company details
Tethis is engaged in the development of liquid biopsy solutions for early cancer detection and improved treatment guidance. The company operates in the healthcare sector, specifically targeting oncology diagnostics. Innovative approaches are utilized to preserve sample integrity through automated and standardized processing. Collaborations with institutions like Sheba Medical Center and Weill Cornell Medicine are maintained to enhance AI-powered diagnostics and cellular residual disease monitoring in cancers such as rectal and early-stage breast cancer.
- Headquarters Milan, Italy
- SectorsTechnologyHealthcare
- Phone•••• ••••
- Website tethis-lab.com
- Social LinkedIn
- Legal Name Tethis S.P.A.
- Total Equity Funding$15.33M (USD)
in 5 rounds
- Latest Funding Round$15.33M (USD), Private Equity Round
Jan 2025
- InvestorsEuropean Union
& 3 more
Products & Services of Tethis
Tethis offers a comprehensive portfolio of products and services, including Liquid Biopsy Solution.
Liquid biopsy is developed for early cancer detection.
Funding Insights of Tethis
Tethis has successfully raised a total of $15.33M across 5 strategic funding rounds. The most recent funding activity was a Private Equity Round of $15.33 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15.33M
- Total Rounds 5
- Last Round Private Equity Round — $15.33M
- Investors Count 4
All 5 funding rounds of Tethis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | $15.33M | Private Equity Round | – | – | |
| Aug 2018 | $58,403 | Grant | – | – | |
| May 2018 | $59,956 | Grant | – | – | |
| Jun 2016 | $340,186 | Grant | – | – | |
| May 2010 | Series A | – | – |
4 investors in total: 4 institutional.
Investors in Tethis
Tethis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, ENEA Tech e Biomedical and sanpaolope.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| eneatechbiomedical.it | ||||
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
| sanpaolope.com |
Investor details for Tethis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Tethis
3 dated milestones of Tethis across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Tethis is founded.
- Funding First funding round.
- Funding Latest funding round, Private Equity Round, of $15.3M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tethis
Complete news archive for Tethis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tethis
Tethis was founded in 2004 and raised its 1st funding round 6 years after it was founded.
Tethis is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.
Tethis is a funded company, having raised a total of $15.33M across 5 funding rounds to date.
Tethis is engaged in the development of liquid biopsy solutions for early cancer detection and improved treatment guidance. The company operates in the healthcare sector, specifically targeting oncology diagnostics. Innovative approaches are utilized to preserve sample integrity through automated and standardized processing. Collaborations with institutions like Sheba Medical Center and Weill Cornell Medicine are maintained to enhance AI-powered diagnostics and cellular residual disease monitoring in cancers such as rectal and early-stage breast cancer.
Tethis offers Liquid Biopsy Solution.
Tethis has 4 investors. Key investors include European Union, ENEA Tech e Biomedical, sanpaolope.com, and EIC Fund.
Tethis operates through Tethis S.P.A..